Results 101 to 110 of about 3,505 (170)

Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extension. [PDF]

Int J Urol, 2021
Honda M, Yokoyama O, Takahashi R, Matsuda T, Nakayama T, Mogi T.   +5 more
europepmc   +1 more source

Urodynamic and Frequency-Volume Chart Parameters Influencing Anticholinergic Resistance in Patients With Neurogenic Detrusor Overactivity. [PDF]

Int Neurourol J
Akarken I, Tarhan H, Sahin H.
europepmc   +1 more source

Concomitant Botulinum Toxin Injections for Neurogenic Detrusor Overactivity and Spasticity-A Retrospective Analysis of Practice and Safety. [PDF]

Toxins (Basel)
Leilaz A, Joussain C, Denys P, Bensmail D, Levy J.   +4 more
europepmc   +1 more source

Real-World Effects of Mirabegron in Patients with Chronic Neurogenic Detrusor Overactivity - A Retrospective Cohort Study. [PDF]

Res Rep Urol, 2020
Krebs J, Pannek J, Rademacher F, Wöllner J.   +3 more
europepmc   +1 more source

Editorial Comment: Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Sys-tematic Review and Meta-Analysis of Randomized Controlled Studies. [PDF]

Int Braz J Urol
Bertoncello GG, Averbeck MA.
europepmc   +1 more source

Percutaneous Tibial Nerve Stimulation's Impact on Sexual Function in Female Patients with Neurogenic Detrusor Overactivity, Sexual Dysfunction, and Multiple Sclerosis. [PDF]

J Clin Med
Zachariou A, Giannakis I, Kaltsas A, Zikopoulos A, Skentou C, Stavros S, Potiris A, Zachariou D, Baltogiannis D, Phuc CHN, Sopheap B, Tien DMB, Sofikitis N.   +12 more
europepmc   +1 more source

Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. [PDF]

Toxins (Basel)
Yu PH, Wang CC.
europepmc   +1 more source

Transcutaneous neuromodulation versus oxybutynin for neurogenic detrusor overactivity in persons with spinal cord injury: A randomized, investigator blinded, parallel group, non-inferiority controlled trial. [PDF]

J Spinal Cord Med
Sahu S, Venkataraman S, Chanu AR, Singh U.   +3 more
europepmc   +1 more source

TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial. [PDF]

BMJ Open, 2020
Birkhäuser V, Liechti MD, Liechti MD, Anderson CE, Bachmann LM, Baumann S, Baumberger M, Birder LA, Botter SM, Büeler S, Cruz CD, David G, Freund P, Friedl S, Gross O, Hund-Georgiadis M, Husmann K, Jordan X, Koschorke M, Leitner L, Luca E, Mehnert U, Möhr S, Mohammadzada F, Monastyrskaya K, Pfender N, Pohl D, Sadri H, Sartori AM, Schubert M, Sprengel K, Stalder SA, Stoyanov J, Stress C, Tatu A, Tawadros C, van der Lely S, Wöllner J, Zubler V, Curt A, Pannek J, Brinkhof MWG, Kessler TM.   +42 more
europepmc   +1 more source

Curative effect observation of botulinum toxin detrusor injection in neurogenic detrusor overactivity

Huli yanjiu, 2018
刘静, 刘艳雨, 谢静仪, 陈瑶, 吴淑卿, 卢秀玲   +5 more
doaj